About SQI Diagnostics (CVE:SQD)
SQI Diagnostics Inc (SQI) is a Canada-based diagnostics company. The Company develops multiplexed tests and automated systems for customers needing to measure a range of biomarkers in blood or other common sample types. It offers three different platforms sqidlite, sqid x and the siqdworks to run and analyze its microarray plates. Its Ig_plex microarrays have the ability to discriminate between individual isotypes of antibodies and antigens and proteins within a single well of a microarray. Its Ig_plex CHEX technology provides multiple in-microarray checks. It has three areas of focus: Testing for the drug development industry, Animal health testing, Human disease testing or deoxyribonucleic acid (DNA) diagnostic testing. In drug development testing, SQI provides technology and equipment for blood testing in clinical trials and pre-clinical research for developing various drugs. It applies its multiplexing technology to diagnostic tests used for customers in the animal health segment.
Industry, Sector and Symbol
Industry Medical Laboratories & Research
Trailing P/E Ratio-3.66666666666667
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-304.33%
Return on Assets-129.49%
SQI Diagnostics (CVE:SQD) Frequently Asked Questions
What is SQI Diagnostics' stock symbol?
SQI Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SQD."
How were SQI Diagnostics' earnings last quarter?
SQI Diagnostics Inc. (CVE:SQD) announced its earnings results on Monday, February, 5th. The company reported ($0.02) earnings per share for the quarter. The firm had revenue of ($0.38) million for the quarter. SQI Diagnostics had a negative return on equity of 304.33% and a negative net margin of 475.53%. View SQI Diagnostics' Earnings History.
When will SQI Diagnostics make its next earnings announcement?
Who are some of SQI Diagnostics' key competitors?
Some companies that are related to SQI Diagnostics include Ocera Therapeutics (OCRX), VolitionRX (VNRX), Electromed (ELMD), Biopharmx (BPMX), Scientific Digital Imaging (SDI), Futura Medical (FUM), Advanced Oncotherapy (AVO), ANGLE (AGL), Concordia International (CXR), Actinium Pharmaceuticals (ATNM), Can Fite Biopharma (CANF), Surgical Innovations (SUN), ReNeuron Group (RENE), Avacta Group (AVCT), Uroplasty (UPI), Repros Therapeutics (RPRX), WaferGen Bio-systems (WGBS) and Akers Biosciences (AKR).
Who are SQI Diagnostics' key executives?
SQI Diagnostics' management team includes the folowing people:
- Andrew Morris, President, Chief Executive Officer, Director
- Patricia Lie, Chief Financial Officer, Vice President of Finance and Administration
- Eric Brouwer Ph.D., Chief Scientific Officer
- Catherine Smith, Vice President - Technology
- Peter D. Winkley, Chairman of the Board
- Clive J. Beddoe, Director (Age 70)
- Gerald R. Connor, Director (Age 71)
- Wilmot L. Matthews, Director (Age 77)
- Allan Pronovost Ph.D., Director (Age 56)
- Claude Ricks, Director
Has SQI Diagnostics been receiving favorable news coverage?
News headlines about SQD stock have trended somewhat positive this week, Accern reports. The research group identifies positive and negative press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. SQI Diagnostics earned a media sentiment score of 0.00 on Accern's scale. They also gave news headlines about the company an impact score of 45.18 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.
How do I buy shares of SQI Diagnostics?
Shares of SQD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is SQI Diagnostics' stock price today?
One share of SQD stock can currently be purchased for approximately C$0.22.
How big of a company is SQI Diagnostics?
SQI Diagnostics has a market capitalization of C$24.41 million.
How can I contact SQI Diagnostics?
SQI Diagnostics' mailing address is 36 Meteor Dr, ETOBICOKE, ON M9W 1A4, Canada. The company can be reached via phone at +1-416-6749500.
MarketBeat Community Rating for SQI Diagnostics (SQD)MarketBeat's community ratings are surveys of what our community members think about SQI Diagnostics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
SQI Diagnostics (CVE:SQD) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
SQI Diagnostics (CVE:SQD) Earnings History and Estimates Chart
SQI Diagnostics (CVE SQD) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/9/2018|| || || || || || || || |
|2/5/2018||Q1 2018||C($0.02)||C($0.38) million||View||N/A|
|11/16/2017||Q4 2017||C($0.01)||C$0.13 million||View||N/A|
|8/24/2017||Q3 2017||C($0.02)||C$0.18 million||View||N/A|
|5/10/2017||Q2 2017||C($0.01)||C$0.25 million||View||N/A|
|2/21/2017||Q1 2017||C($0.02)||C$0.42 million||View||N/A|
|12/6/2016||Q4 2016||C($0.02)||C$0.71 million||View||N/A|
|8/18/2016||Q3 2016||C($0.02)||C$0.24 million||View||N/A|
|5/13/2016||Q2 2016||C($0.01)||C$0.28 million||View||N/A|
|2/11/2016||Q1 2016||C($0.02)||C$0.20 million||View||N/A|
|12/16/2015||Q4 2015||C($0.03)||C$0.18 million||View||N/A|
|8/18/2015||Q3 2015||C($0.03)||C$0.18 million||View||N/A|
|5/21/2015||Q2 2015||C($0.03)||C$0.07 million||View||N/A|
|2/26/2015||Q1 2015||C($0.02)||C$0.02 million||View||N/A|
|12/17/2014||Q4 2014||C($0.03)||C$0.07 million||View||N/A|
|5/12/2014||Q2 2014||C($0.02)||C$0.02 million||View||N/A|
SQI Diagnostics (CVE:SQD) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for SQI Diagnostics (CVE:SQD)
No dividend announcements for this company have been tracked by MarketBeat.com
SQI Diagnostics (CVE SQD) Insider Trading and Institutional Ownership History
SQI Diagnostics (CVE SQD) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|2/20/2018||Gerald R Connor||Director||Sell||29,283||C$0.17||C$4,978.11|
|2/16/2018||Private Wealth Mana Cumberland||Insider||Buy||7,000||C$0.19||C$1,330.00|
|2/8/2018||Gerald R Connor||Director||Sell||7,000||C$0.17||C$1,190.00|
|12/11/2017||Gerald R Connor||Director||Sell||189,000||C$0.16||C$30,240.00|
SQI Diagnostics (CVE SQD) News Headlines
SQI Diagnostics (CVE:SQD) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
SQI Diagnostics (CVE SQD) Stock Chart for Tuesday, March, 20, 2018